ORIGINAL RESEARCH article

Front. Pharmacol., 08 August 2018

Sec. Ethnopharmacology

Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.00881

RETRACTED: Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3

Retracted

Song Wu&#x;Song Wu1†Yuling Qiu&#x;Yuling Qiu2†Yingying ShaoYingying Shao1Shuangshuang YinShuangshuang Yin1Rui WangRui Wang1Xu PangXu Pang1Junhong MaJunhong Ma3Chunze ZhangChunze Zhang4Bo WuBo Wu5Sangho KooSangho Koo6Lifeng HanLifeng Han1Yi ZhangYi Zhang1Xiumei GaoXiumei Gao1Tao Wang*Tao Wang1*Haiyang Yu*Haiyang Yu1*
  • 1Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
  • 2School of Pharmacy, Tianjin Medical University, Tianjin, China
  • 3Department of Gastrointestinal Surgery, Nankai Hospital, Tianjin, China
  • 4Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China
  • 5School of Fundamental Sciences, China Medical University, Shenyang, China
  • 6Department of Chemistry, Myongji University, Seoul, South Korea

Citation: Wu S, Qiu Y, Shao Y, Yin S, Wang R, Pang X, Ma J, Zhang C, Wu B, Koo S, Han L, Zhang Y, Gao X, Wang T and Yu H (2018) Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3. Front. Pharmacol. 9:881. doi: 10.3389/fphar.2018.00881

Received: 22 May 2018; Accepted: 20 July 2018;
Published: 08 August 2018; Retracted: 25 March 2025.

Edited by:

Karl Tsim, Hong Kong University of Science and Technology, Hong Kong

Reviewed by:

Li-Wha Wu, National Cheng Kung University, Taiwan
Songxiao Xu, Artron BioResearch, Inc., Canada

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.